Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion type Assertion NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_head.
- NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion description "[The amyloid hypothesis does not adequately address the pathogenesis of the disease, however, since transgenic mice that express the pathologic mutations of the APP and presenilin-1 (PS1) genes produce amyloid plaques but fail to exhibit neurodegeneration and memory loss observed in AD patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_provenance.
- NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion evidence source_evidence_literature NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_provenance.
- NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion SIO_000772 17981591 NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_provenance.
- NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion wasDerivedFrom befree-2016 NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_provenance.
- NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_assertion wasGeneratedBy ECO_0000203 NP638671.RAwB-dNB5fmBFjg_CTp5AmfufgnwwTPSVzmPovnLZ6FyQ130_provenance.